Related Experiment Video
Updated: Aug 18, 2026

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes
Published on: September 24, 2013
Impaired Ca2+ handling and contraction in cardiomyocytes from mice with a dominant negative thyroid hormone receptor
Pasi Tavi1, Maria Sjögren, Per Kristian Lunde
1Department of Physiology and Pharmacology, Karolinska Institute, SE-171 77 Stockholm, Sweden.
Insights
Thyroid hormone receptor alpha 1 (TRalpha1) mutations cause heart dysfunction, mimicking hypothyroidism. TRalpha1+m mice show slowed cardiomyocyte contractions and calcium transients, revealing critical roles for TRalpha1 in cardiac function.
Area of Science:
- Cardiology
- Endocrinology
- Molecular Biology
Background:
- Thyroid hormone (TH) profoundly impacts cardiac development and function via thyroid hormone receptors (TR) alpha(1) and beta(1).
- While TRbeta(1) mutations are documented in patients, TRalpha(1) mutations remain undiscovered, potentially due to normal TH levels in affected individuals.
- TRalpha(1)+/m mice possess a dominant-negative TRalpha(1) mutation, offering a model to study TRalpha(1) function in vivo.
Purpose of the Study:
- To investigate the functional consequences of a dominant-negative TRalpha(1) mutation on cardiomyocyte calcium (Ca2+) handling and contractility.
- To compare the cardiac phenotype of TRalpha(1)+/m mice with wildtype (WT) littermates and assess responses to varying stimulation frequencies and beta-adrenergic stimulation.
- To elucidate the role of TRalpha(1) in regulating cardiac function and identify potential therapeutic targets.
Main Methods:
- Isolation and functional assessment of cardiomyocytes from TRalpha(1)+/m mice and WT littermates.
- Measurement of intracellular Ca2+ transients and cell shortening (contractions) under various stimulation conditions (frequency, beta-adrenergic stimulation).
- Assessment of TH treatment effects and analysis of phospholamban (PLB) expression in excised hearts.
Main Results:
- TRalpha(1)+/m cardiomyocytes exhibited significantly slowed Ca2+ transients and contractions, mirroring a hypothyroid phenotype.
- Increased stimulation frequency or beta-adrenergic stimulation partially normalized differences but induced diastolic Ca2+ abnormalities and spontaneous Ca2+ release in TRalpha(1)+/m cells.
- TH treatment normalized cardiac function in both TRalpha(1)+/m and WT cardiomyocytes, while TRalpha(1)+/m hearts showed increased PLB expression.
Conclusions:
- Isolated TRalpha(1)+/m cardiomyocytes display significant functional deficits, characterized by impaired Ca2+ handling and contractility.
- These findings highlight the critical role of TRalpha(1) in maintaining normal cardiac electrophysiology and contractility.
- The TRalpha(1)+/m mouse model provides valuable insights into TRalpha(1)-mediated cardiac dysfunction and potential therapeutic strategies.
Abstract:
The profound effects of thyroid hormone (TH) on heart development and function are mediated by the thyroid hormone receptors (TR) alpha(1) and beta(1). While numerous patients with TRbeta(1) mutations have been identified, patients with similar mutations in TRalpha(1) are yet to be discovered. Recently generated heterozygous mice with a dominant negative mutation in TRalpha(1) (TRalpha(1)+/m mice) have normal TH levels, which may have hampered the discovery of patients with such mutations. We now measure intracellular Ca(2+) and contraction in cardiomyocytes isolated from TRalpha(1)+/m mice and wildtype littermates (WT). TRalpha(1)+/m cardiomyocytes showed a phenotype similar to that in hypothyroidism with significant slowing of voltage-activated Ca(2+) transients and contractions. Increased stimulation frequency (from 0.5 to 3 Hz) or beta-adrenergic stimulation reduced the differences between TRalpha(1)+/m and WT cardiomyocytes. However, in TRalpha(1)+/m cells stimulation at 3 Hz gave a marked increase in diastolic Ca(2+) and beta-adrenergic stimulation triggered spontaneous Ca(2+) release events during relaxation. Both TRalpha(1)+/m and WT cardiomyocytes responded to TH treatment by displaying a "hyperthyroid" phenotype with faster and larger Ca(2+) transients and contractions. Excised TRalpha(1)+/m hearts showed an increased expression of phospholamban (PLB). In conclusion, isolated TRalpha(1)+/m cardiomyocytes display major dysfunctions with marked slowing of the Ca(2+) transients and contractions.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
G-Protein Gated Ion Channels
Sensory organs,...

